IP Library Granted Patent US 8,652,845
Granted Patent B2
US 8,652,845 · App. 13/635,679 · Granted Feb 18, 2014

Method for producing mesodermal cells by culturing under adherent conditions and without co-culture with cells from a different species in a serum-free medium

Inventors: Akira Niwa (Kyoto, JP); Tatsutoshi Nakahata (Kyoto, JP); Toshio Heike (Kyoto, JP)
Assignee: Kyoto University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,652,845
App. No.
13/635,679
Granted
Feb 18, 2014
Kind
B2
Abstract

The present invention provides a method for inducing differentiation of pluripotent stem cells into mesodermal cells, comprising the step of culturing pluripotent stem cells in a serum-free medium without forming an embryoid body and without coculturing with cells from a different species.

Claims (18)

1. A method for producing mesodermal cells comprising:

a) culturing pluripotent stem cells under adherent conditions and without co-culture with cells from a different species in a serum-free medium comprising BMP4 without Wnt3a;

b) culture the cells of step (a) under adherent conditions and without co-culture with cells from a different species in a serum-free medium comprising BMP4 and Wnt3a; and

c) culturing the cells of step (b) under adherent conditions and without co-culture with cells from a different species in a serum-free medium comprising VEGF and Wnt3a,

thereby producing mesodermal cells containing hematopoietic stem cells and/or hematopoietic progenitor cells.

2. The method according to claim 1 , wherein the serum-free medium at step (3) further comprises SCF.

3. The method according to claim 1 , wherein the cells in steps (a), (b) and (c) are cultured on a Matrigel™ coating dish.

4. The method according to claim 1 , wherein the step (a) is performed for 1 day.

5. The method according to claim 1 , wherein the step (b) is performed for 3 days.

6. The method according to claim 1 , wherein the step (c) is performed for 2 days.

7. The method according to claim 1 , wherein said mesodermal cells contain KDR-positive and CD34-positive cells.

8. A method for producing hematopoietic stem cells, hematopoietic progenitor cells, myeloid cells, megakaryocytes, erythrocytes and/or neutrophils, comprising:

a) culturing pluripotent stem cells under adherent conditions and without co-culture with cells from a different species in a serum-free medium comprising BMP4 without Wnt3a;

b) culture the cells of step (a) under adherent conditions and without co-culture with cells from a different species in a serum-free medium comprising BMP4 and Wnt3a; and

c) culturing the cells of step (b) under adherent conditions and without co-culture with cells from a different species in a serum-free medium comprising VEGF and Wt3a,

d) culturing the mesodermal cells obtained in step (c) in the presence of a hematopoietic factor(s) selected from the group consisting of SCF, TPO, EPO, IL-3, Flt3-1igand, FP-6 and G-CSF,

thereby producing hematopoietic stem cells, hematopoietic progenitor cells, myeloid cells, megakaryocytes, erythrocytes and/or neutrophils.

9. The method according to claim 8 , wherein the step (b) is performed for 9 days or more.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2014
From: NIWA, AKIRA; NAKAHATA, TATSUTOSHI; HEIKE, TOSHIO
To: KYOTO UNIVERSITY
Reel/Frame 031882/0986 →
Continuity (2)
Provisional Application 61315170 · Mar 18, 2010
Related Publication 20130011924A1 · Jan 10, 2013